CANDRIAM S.C.A. – Celldex Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$11.76M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +43.92% | 127.71K shares | 3.92M | $28.11 | 418.50K |
| Q2 2022 | share | Increase | +4.80% | 13.31K shares | -1.61M | $26.96 | 290.79K |
| Q1 2022 | share | Decrease | -28.34% | -109.74K shares | -5.51M | $34.06 | 277.48K |
| Q4 2021 | share | Increase | +114.86% | 206.99K shares | 5.23M | $38.9 | 387.22K |
| Q3 2021 | share | Decrease | -54.91% | -219.46K shares | -3.63M | $53.99 | 180.22K |
| Q2 2021 | share | Increase | +16.14% | 55.54K shares | 7.57M | $33.44 | 399.68K |
| Q1 2021 | share | 0.00% | 0 shares | -238K | $20.6 | 344.13K | |
| Q4 2020 | share | Increase | 0.00% | 344.13K shares | 6.03M | $17.52 | 344.13K |